QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
TSE:NWH.UN

NorthWest Health Prop Real Est Inv Trust - NWH.UN Stock Forecast, Price & News

C$13.16
+0.10 (+0.77%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
C$13.02
C$13.11
50-Day Range
C$11.91
C$13.34
52-Week Range
C$11.85
C$14.42
Volume
N/A
Average Volume
497,558 shs
Market Capitalization
C$2.83 billion
P/E Ratio
7.52
Dividend Yield
6.13%
Price Target
C$14.97
NWH.UN stock logo

About NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages 230 professionals across nine offices in five countries to serve as a long-term real estate partner to leading healthcare operators.

NorthWest Health Prop Real Est Inv Trust Trading Up 0.5 %

Shares of TSE:NWH.UN traded up C$0.06 during midday trading on Thursday, hitting C$13.12. The company had a trading volume of 209,600 shares, compared to its average volume of 495,682. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 85.42. NorthWest Health Prop Real Est Inv Trust has a 12 month low of C$11.85 and a 12 month high of C$14.42. The firm has a fifty day simple moving average of C$12.61 and a 200 day simple moving average of C$13.17. The stock has a market cap of C$2.82 billion and a price-to-earnings ratio of 7.22.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on NWH.UN shares. National Bankshares dropped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$15.50 to C$14.00 in a research note on Tuesday. CIBC cut their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$15.50 to C$14.75 in a research note on Monday, June 27th. Finally, BMO Capital Markets upgraded NorthWest Health Prop Real Est Inv Trust from a "market perform" rating to a "buy" rating and lowered their price objective for the company from C$15.00 to C$13.75 in a research note on Monday, July 4th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of C$14.97.

Receive NWH.UN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NorthWest Health Prop Real Est Inv Trust and its competitors with MarketBeat's FREE daily newsletter.

NWH.UN Stock News Headlines

NorthWest Healthcare: Keep Your Eye On That Leverage
This Healthcare REIT Still Offers Good Value
NORTHWEST HEALTHCARE PPTYS REIT UNITS
Housing Crisis: 3 REITs to Beat the Blues
See More Headlines
Receive NWH.UN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NorthWest Health Prop Real Est Inv Trust and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
REIT - Healthcare Facilities
Sub-Industry
N/A
Current Symbol
TSE:NWH.UN
CIK
N/A
Fax
N/A
Employees
213
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$14.97
High Stock Price Forecast
C$16.00
Low Stock Price Forecast
C$13.75
Forecasted Upside/Downside
+13.8%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$520.97 million
Cash Flow
C$0.43 per share
Book Value
C$10.57 per share

Miscellaneous

Free Float
N/A
Market Cap
C$2.83 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Paul Dalla Lana (Age 53)
    Chairman & CEO
  • Mr. Craig Douglas Mitchell BComm
    EMBA, FCPA, Pres & CEO of NorthWest Healthcare Properties Management (ANZ)
  • Mr. Shailen Chande CPA
    CA, Chief Financial Officer
  • Mr. Jan Krizan C.F.A. (Age 51)
    CFA, Managing Director of Europe
    Comp: $2.38M
  • Mr. Peter Riggin (Age 57)
    COO & MD of Canada
  • Mr. Mike Brady
    Exec. VP, Gen. Counsel & Sec.
  • Mr. Gerson Amado
    Managing Director of Brazil
  • Mr. Dave Casimiro
    Sr. VP of Canadian Operations
  • Timothy Blackwell
    Exec. VP of Funds Management
  • Mr. Terry Schmitt
    Regional Gen. Mang. of Western Canada













NWH.UN Stock - Frequently Asked Questions

Should I buy or sell NorthWest Health Prop Real Est Inv Trust stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NorthWest Health Prop Real Est Inv Trust in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NWH.UN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NWH.UN, but not buy additional shares or sell existing shares.
View NWH.UN analyst ratings
or view top-rated stocks.

What is NorthWest Health Prop Real Est Inv Trust's stock price forecast for 2022?

7 Wall Street research analysts have issued 12 month target prices for NorthWest Health Prop Real Est Inv Trust's shares. Their NWH.UN share price forecasts range from C$13.75 to C$16.00. On average, they anticipate the company's share price to reach C$14.97 in the next year. This suggests a possible upside of 14.6% from the stock's current price.
View analysts price targets for NWH.UN
or view top-rated stocks among Wall Street analysts.

How have NWH.UN shares performed in 2022?

NorthWest Health Prop Real Est Inv Trust's stock was trading at C$13.81 at the beginning of the year. Since then, NWH.UN stock has decreased by 5.4% and is now trading at C$13.06.
View the best growth stocks for 2022 here
.

Is NorthWest Health Prop Real Est Inv Trust a good dividend stock?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) pays an annual dividend of C$0.80 per share and currently has a dividend yield of 6.13%. NWH.UN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 44.20%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NWH.UN.

What is NorthWest Health Prop Real Est Inv Trust's stock symbol?

NorthWest Health Prop Real Est Inv Trust trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NWH.UN."

How do I buy shares of NorthWest Health Prop Real Est Inv Trust?

Shares of NWH.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is NorthWest Health Prop Real Est Inv Trust's stock price today?

One share of NWH.UN stock can currently be purchased for approximately C$13.06.

How much money does NorthWest Health Prop Real Est Inv Trust make?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) has a market capitalization of C$2.81 billion and generates C$518.03 million in revenue each year.

How many employees does NorthWest Health Prop Real Est Inv Trust have?

The company employs 213 workers across the globe.

How can I contact NorthWest Health Prop Real Est Inv Trust?

NorthWest Health Prop Real Est Inv Trust's mailing address is 284 King St E Suite 100, TORONTO, ON M5A 1K4, Canada. The official website for the company is www.nwhp.ca. The company can be reached via phone at +1-416-3662000.

This page (TSE:NWH.UN) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.